During the past decade, Wasatch Clinical Research conducted 53 clinical trials. In the 10-year time frame, 53 clinical trials started and 32 clinical trials were completed, i.e. on average, 60.4% percent of trials that started reached the finish line to date. In the past 5 years, 24 clinical trials started and 21 clinical trials were completed. i.e. 87.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Wasatch Clinical Research" #1 sponsor was "Pfizer" with 13 trials, followed by "Urovant Sciences GmbH" with 4 trials sponsored, "Eli Lilly and Company" with 3 trials sponsored, "JANSSEN Alzheimer Immunotherapy Research & Development, LLC" with 3 trials sponsored and "Purdue Pharma LP" with 3 trials sponsored. Other sponsors include 50 different institutions and companies that sponsored additional 51 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Wasatch Clinical Research" #1 collaborator was "Pfizer" with 3 trials as a collaborator, "Bristol-Myers Squibb" with 2 trials as a collaborator, "CoLucid Pharmaceuticals" with 2 trials as a collaborator, "Integrium" with 2 trials as a collaborator and "APCER Life Sciences" with 1 trials as a collaborator. Other collaborators include 8 different institutions and companies that were collaborators in the rest 18 trials.

According to Clinical.Site data, the most researched conditions in "Wasatch Clinical Research" are "Alzheimer's Disease" (9 trials), "Migraine" (6 trials), "Overactive Bladder" (5 trials), "Ulcerative Colitis" (4 trials) and "Alzheimer Disease" (3 trials). Many other conditions were trialed in "Wasatch Clinical Research" in a lesser frequency.

Most popular intervention types in "Wasatch Clinical Research" are "Drug" (74 trials), "Biological" (7 trials), "Other" (7 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (34 trials), "placebo" (4 trials), "Buprenorphine transdermal patch" (3 trials), "Placebo Control" (3 trials) and "Vibegron" (3 trials). Other intervention names were less common.

The vast majority of trials in "Wasatch Clinical Research" are 69 trials for "All" genders, 10 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Wasatch Clinical Research". undefined are not yet recruiting, 10 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 53 completed trials in Wasatch Clinical Research, undefined suspended trials, and 11 terminated clinical trials to date.

Out of the total trials that were conducted in Wasatch Clinical Research, 2 "Phase 1" clinical trials were conducted, 30 "Phase 2" clinical trials and 48 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 1 trials that are defined as “Not Applicable".